Sernova Corp.
SVA
Rank in Stocks
#24926
Sernova Corp. is a Canadian clinical-stage enterprise specializing in the... Sernova Corp. is a Canadian clinical-stage enterprise specializing in the development and commercialization of groundbreaking regenerative medicine therapies. Its core endeavors revolve around its proprietary Cell Pouch system and associated technologies, which encompass specialized therapeutic cells and mechanisms for localized cellular immune protection. The Cell Pouch itself is an innovative medical device engineered to establish a highly vascularized tissue environment, crucial for the successful transplantation and engraftment of therapeutic cells. Once integrated, these cells are designed to secrete vital proteins or hormones, providing sustained treatment for a range of severe chronic conditions, including diabetes, hemophilia, and thyroid dysfunction. To bolster its research and development, Sernova maintains a collaborative partnership with AgeX Therapeutics, Inc. focused on generating immune-protected therapeutic cells, and an ongoing research agreement with the University of Miami to further refine its Cell Pouch cell therapy platform. Established in 1998, Sernova Corp. maintains its corporate headquarters in London, Canada.
Share Price
$0.07789596
Last synced: 2026-11-09
Market Cap
$29.42M
Change (1 day)
0.00%
Change (1 year)
-22.05%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sernova Corp. (SVA)
Category
Healthcare
EPS for Sernova Corp. (SVA)
EPS as of July 2026 TTM: $-0.02
According to Sernova Corp.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.07.
EPS history for Sernova Corp. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -30.00% |
| 2025 | $-0.03 | -52.37% |
| 2024 | $-0.07 | -23.37% |
| 2023 | $-0.09 | 42.19% |
| 2022 | $-0.07 | 185.28% |
| 2021 | $-0.02 | 12.14% |
| 2020 | $-0.02 | 19.77% |
| 2019 | $-0.02 | -2.27% |
| 2018 | $-0.02 | 35.38% |
| 2017 | $-0.01 | 3.17% |
| 2016 | $-0.01 | -21.25% |
| 2015 | $-0.02 | -14.89% |
| 2014 | $-0.02 | 20.51% |
| 2013 | $-0.02 | -34.73% |
| 2012 | $-0.02 | 2.14% |
| 2011 | $-0.02 | -4.88% |
| 2010 | $-0.02 | 6.03% |
| 2009 | $-0.02 | -45.28% |
| 2008 | $-0.04 | -45.22% |
| 2007 | $-0.08 | 146.50% |
| 2006 | $-0.03 | 121.13% |
| 2005 | $-0.01 | -2.74% |
| 2004 | $-0.01 | -48.77% |
| 2003 | $-0.03 | -52.97% |
| 2002 | $-0.06 | -35.87% |
| 2001 | $-0.09 | 260.69% |
| 2000 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -74,671.43% |
US
|
|
| $-7.07 | 33,566.67% |
US
|
|
| $-5.29 | 25,090.48% |
AU
|
|
| $12.88 | -61,433.81% |
BE
|
|
| $21.56 | -102,766.67% |
NL
|
Questions about Sernova Corp.'s earnings per share (EPS)
What is Sernova Corp.'s earnings per share (EPS)?
Sernova Corp.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jul 2026.
What was Sernova Corp.'s earnings per share (EPS) in 2025?
In 2025, Sernova Corp.'s earnings per share (EPS) was $-0.03, compared with $-0.07 in 2024.
How has Sernova Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sernova Corp.'s earnings per share (EPS) was highest in 2021 ($-0.02) and lowest in 2023 ($-0.09).
How does Sernova Corp.'s earnings per share (EPS) compare with similar companies?
Sernova Corp.'s earnings per share (EPS) ($-0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.